Every finding on this page is sourced directly from the Auditor General of Ontario, Health Canada, and the Ontario government's own fraud prevention disclosures. Medisyns does not manufacture the problem — it is documented in official records.
Source integrity policy: Every statistic on this page is cited with its primary source URL. We do not use secondary sources, industry estimates, or aggregator sites. If a number cannot be traced to a government document, auditor report, or peer-reviewed study, it does not appear here. Sources are dated — where data is from an earlier audit, this is noted explicitly.
In 2016/17, the Ontario Ministry of Health inspected just 286 of more than 4,260 pharmacies — 6.7% of the total. Those inspections recovered $9.1 million in inappropriate claims. The Auditor General separately identified a further $3.9 million in inappropriate claims the Ministry did not inspect or recover. The Ministry was found to lack an overall inspection strategy to target high-risk pharmacies.
Total expenditures of the Ontario Drug Benefit Program in 2016/17 were approximately $5.4 billion, serving approximately 4 million recipients. The Auditor General concluded the Ministry was not recovering many invalid claims and payments to pharmacists. Against a program of this scale, even a fraction of a percent in fraud or inappropriate billing represents tens of millions of dollars of undetected losses.
In May 2023, a pharmacy somewhere in Ontario reported the loss of more than 245,000 hydromorphone (Dilaudid) tablets to Health Canada. There was no robbery and no break-in. The official reason recorded by Health Canada: "Loss unexplained." There is no legal requirement to report such losses to police. The Ontario College of Pharmacists launched an investigation but could not provide further details.
The Ontario government's own fraud prevention page acknowledges duplicate prescriptions — obtaining the same drug from multiple pharmacies — and "double doctoring" (obtaining opioid prescriptions from three or more doctors in a month) as active fraud vectors in the ODB program. No cross-system real-time verification layer exists that would catch these events before dispensing occurs.
Data currency note: The Ontario Auditor General's most recent Value-for-Money audit of the Ontario Drug Benefit Program was published in 2017 (audit period 2016/17). The pharmacy inspection figures and recovery amounts reflect that audit period and are the most recent audited figures available from a primary government source. The 2023 CBC News/Health Canada data is current as of the publication date.
The Auditor General found Ontario inspects 6.7% of pharmacies and still missed $3.9M in inappropriate claims. The government's own fraud page acknowledges duplicate prescriptions and double-doctoring as known problems — with no real-time solution. Medisyns connects the ODB system, private insurers, prescribers, and pharmacies. Every fill is cross-checked before it is dispensed. Duplication is caught at authorization, not discovered in a retrospective audit years later.
Fraud flags fire before the drug leaves the pharmacy — not after a retrospective audit that catches 6.7% of pharmacies every 15 years.
Ontario's 8M+ dual-insured residents have prescriptions split across OHIP and private plans. Medisyns connects both in real time.
Every dispense event logged continuously. No need to wait for the next inspection cycle to discover what went wrong.
Medisyns is in active conversations with provincial health systems. If you work in or with provincial health policy, procurement, or health IT — we'd like to talk.